Skip to main content
ASCO 2023 Highlights
Preclinical and Early Clinical Data Show Promising Antitumor Activity With the HER2 Inhibitor ZN-1041 in Patients With Breast Cancer and Brain Metastases
Read More
FDA Updates
Epkinly FDA Approved for Relapsed or Refractory Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma
Read More
FDA Updates
Lynparza FDA Approved, in Combination With Abiraterone and Prednisone (or Prednisolone), for Metastatic Castration-Resistant Prostate Cancer With BRCA Mutation
Read More
FDA Updates
Polivy Received New Indication for First-Line Treatment of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, and High-Grade B-Cell Lymphoma
Read More
FDA Updates
Omisirge FDA Approved for Patients With Hematologic Malignancies to Reduce Time to Neutrophil Recovery and Infection
Read More
Original Research, Chemotherapy, Oral Therapy, Adverse Events, VEGF Inhibitors
Stopping Oral Chemotherapy Agents With a High Bleeding Risk Before and After Minor Surgical Procedures
Dennis Marjoncu, PharmD, BCOP; Jenna Carmichael, PharmD, BCOP; Benjamin J. Andrick, PharmD, BCOP; Jacqueline Oxenberg, DO, FACS, FACOS
Read More
Original Research, Pediatric Cancer, Adverse Events, Chemotherapy, Infections
Incidence and Severity of Neuropathy with Concurrent Use of Voriconazole and Vincristine in Pediatric Patients with Cancer
Ashley Sabus, PharmD, BCOP; Mya Merrow, PharmD, BCOP; Ellen Burke, PharmD, BCOP; Gordon Kordas, MS; Megan Williams, PharmD; Maria Larson, PT, DPT, PCS; Kristen Eisenman, MD
Read More
Practical Issues in Pharmacy Management, Chemotherapy, Oncology Pharmacy Programs/Protocols, Oral Therapy
Oral Chemotherapy Program Metrics: Results of a National Survey
Olivia G. Fahey, PharmD, BCOP; Sally Y. Barbour, PharmD, BCOP, CPP, FHOPA; Mary A. Golf, PharmD, BCOP; Darcy K. Malard Johnson, PharmD; Rachael M. Morgan, PharmD, BCOP; Melissa J. Rhoades, PharmD, BCOP; Kate D. Taucher, PharmD, MHA, BCOP, FASHP; John M. Valgus, PharmD, MHA, BCOP
Read More
Case Reports, Breast Cancer, Adverse Events, CDK4/6 Inhibitors
Palbociclib-Induced Hepatotoxicity in a Patient with Metastatic Breast Cancer: A Case Report
Jennifer A. Hutchinson, PharmD, BCOP; Jenna Green, BS, PharmD; Christopher Jacques, PharmD; Ju Hee Kim, PharmD; Dana Haggett, MS, RN, FNP-BC; Olivia Straw, MSN, ACNP-BC, AOCNP; Jennifer Shin, MD, MPH
Read More
Case Reports, Transplant, Adverse Events, Leukemia, Pediatric Cancer
Novel Use of Ravulizumab in Transplant-Associated Thrombotic Microangiopathy: Case Report
Manuel R. Gonzales, MD; Jason C. White, DO; Kimberly A. Davidow, MD; David S. Mangum, MD; Kailey E. Grimm, PharmD, BCPPS
Read More
Page 36 of 199
Results 351 - 360 of 1986